BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17214580)

  • 1. Targeting B cells in SLE: the experience with rituximab treatment (anti-CD20).
    Eisenberg R
    Endocr Metab Immune Disord Drug Targets; 2006 Dec; 6(4):345-50. PubMed ID: 17214580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell-targeted therapy for systemic lupus erythematosus.
    Sabahi R; Anolik JH
    Drugs; 2006; 66(15):1933-48. PubMed ID: 17100405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLE - Rituximab in lupus.
    Eisenberg R
    Arthritis Res Ther; 2003; 5(4):157-9. PubMed ID: 12823844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of inflammatory immunologic disease 4. B cell targeting therapy using the anti-CD20 antibody rituximab in inflammatory autoimmune diseases.
    Tanaka Y
    Intern Med; 2007; 46(16):1313-5. PubMed ID: 17704614
    [No Abstract]   [Full Text] [Related]  

  • 6. B-cell biology and related therapies in systemic lupus erythematosus.
    Ahmed S; Anolik JH
    Rheum Dis Clin North Am; 2010 Feb; 36(1):109-30, viii-ix. PubMed ID: 20202594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell depletion in SLE: clinical and trial experience with rituximab and ocrelizumab and implications for study design.
    Reddy V; Jayne D; Close D; Isenberg D
    Arthritis Res Ther; 2013; 15 Suppl 1(Suppl 1):S2. PubMed ID: 23566295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connective tissue diseases: The conundrum of B cell depletion in SLE.
    Sanz I
    Nat Rev Rheumatol; 2009 Jun; 5(6):304-5. PubMed ID: 19491910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in B-cell targeting therapy for the treatment of systemic lupus erythematosus].
    Tanaka Y
    J UOEH; 2011 Jun; 33(2):173-81. PubMed ID: 21702122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD20 monoclonal antibody in rheumatoid arthritis and systemic lupus erythematosus.
    Goldblatt F; Isenberg DA
    Handb Exp Pharmacol; 2008; (181):163-81. PubMed ID: 18071946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective B cell depletion with rituximab in the treatment of autoimmune diseases.
    Kneitz C; Wilhelm M; Tony HP
    Immunobiology; 2002 Dec; 206(5):519-27. PubMed ID: 12607727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B-cell-targeted therapy for systemic lupus erythematosus: an update.
    Ding C; Foote S; Jones G
    BioDrugs; 2008; 22(4):239-49. PubMed ID: 18611066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab (anti-CD20 monoclonal antibody) for refractory systemic lupus erythematosus: report of one case].
    Sabugo F; Llanos C; Soto L; GutiƩrrez J; Cuchacovich M
    Rev Med Chil; 2005 Jun; 133(6):681-4. PubMed ID: 16075133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell depletion therapy in systemic lupus erythematosus.
    Anolik J; Sanz I; Looney RJ
    Curr Rheumatol Rep; 2003 Oct; 5(5):350-6. PubMed ID: 12967516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of cold agglutinin disease with anti-CD20 antibody (rituximab) in a patient with systemic lupus erythematosus.
    Kotani T; Takeuchi T; Kawasaki Y; Hirano S; Tabushi Y; Kagitani M; Makino S; Hanafusa T
    Lupus; 2006; 15(10):683-5. PubMed ID: 17120596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of SLE with anti-CD20 monoclonal antibody.
    Looney RJ; Anolik J; Sanz I
    Curr Dir Autoimmun; 2005; 8():193-205. PubMed ID: 15564722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus.
    Albert D; Dunham J; Khan S; Stansberry J; Kolasinski S; Tsai D; Pullman-Mooar S; Barnack F; Striebich C; Looney RJ; Prak ET; Kimberly R; Zhang Y; Eisenberg R
    Ann Rheum Dis; 2008 Dec; 67(12):1724-31. PubMed ID: 18250115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab - shadow, illusion or light?
    van Vollenhoven RF
    Autoimmun Rev; 2012 Jun; 11(8):563-7. PubMed ID: 22036829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.